Empiric therapy of bacterial infections in severe neutropenia

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
The changing epidemiology of severe infections in the ICU
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties  J. Maugein, D. Guillemot, M.J. Dupont, T. Fosse,
Hydatid disease Clinical Microbiology and Infection
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Non-antibiotic strategies for sepsis
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility  Javier Garau, Walter Wilson,
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
Cephalosporins: a pharmacological update
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
Sepsis and neutropenia induced by clozapine
Uncommon opportunistic fungi: new nosocomial threats
Elements of design: the knowledge on which we build
André Bryskier  Clinical Microbiology and Infection 
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy  D. Nathwani, J.-J.
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
A. Bryskier  Clinical Microbiology and Infection 
Pathogenesis of catheter-related infections: lessons for new designs
Community-acquired pneumonia: epidemiologic and clinical consideration
Training in infectious diseases and tropical medicine in Britain
Definition of the Clinical Antibacterial Spectrum of Activity
Clinical infection services—the Leiden experience
Ethan Rubinstein, Itzhak Levy  Clinical Microbiology and Infection 
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Clinical Microbiology and Infection
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
W. Eugene Sanders, Christine C. Sanders 
Overview of cefixime use in community-acquired infections
Sanford Chodosh  Clinical Microbiology and Infection 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Carratalà J.   Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
Typing of Clostridium difficile
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis  Bernard Grenier  Clinical.
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

Empiric therapy of bacterial infections in severe neutropenia Michel Glauser, Marc Boogaerts, Catherine Cordonnier, Jan Palmblad, Pietro Martino  Clinical Microbiology and Infection  Volume 3, Pages S77-S86 (April 1997) DOI: 10.1111/j.1469-0691.1997.tb00648.x Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Trends in single organism bacteremia in eight EORTC trials over a 20-year period. Clinical Microbiology and Infection 1997 3, S77-S86DOI: (10.1111/j.1469-0691.1997.tb00648.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions